Skip to main content

and
  1. Article

    Open Access

    Safety analysis of new medications in clinical trials: a simulation study to assess the differences between cause-specific and subdistribution frameworks in the presence of competing events

    Safety is an essential part of the evaluation of new medications and competing risks that occur in most clinical trials are a well identified challenge in the analysis of adverse events. Two statistical framew...

    Astrid Genet, Kathrin Bogner, Ralf Goertz, Sarah Böhme in BMC Medical Research Methodology (2023)

  2. Article

    Open Access

    Surrogate threshold effect based on a meta-analysis for the predictive value of progression-free survival for overall survival in hormone receptor-positive, HER2-negative metastatic breast cancer

    Clinical trials investigating therapies for metastatic breast cancer (mBC) generally use progression-free survival (PFS) as primary endpoint, which is not accepted as patient-relevant outcome within the German...

    Michael Patrick Lux, Sarah Böhme in Breast Cancer Research and Treatment (2019)